<DOC>
	<DOCNO>NCT00959569</DOCNO>
	<brief_summary>This large randomize double-blind clinical trial ( esmolol v placebo ) enroll patient undergoing cardiac surgery study additive cardiac protection therapeutic strategy .</brief_summary>
	<brief_title>Esmolol Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>end diastolic diameter &gt; 60 mm ejection fraction &lt; 50 % write informed consent age &gt; 18 year previous unusual response esmolol inclusion randomize study esmolol administration previous 30 day emergency operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>esmolol</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>cardiac anesthesia</keyword>
	<keyword>mortality</keyword>
	<keyword>beta blocker</keyword>
	<keyword>beta-blockers</keyword>
	<keyword>cardiac protection</keyword>
</DOC>